Results 291 to 300 of about 1,236,932 (359)

Microneedle Technology in Psoriasis Management: Mechanistic Insights, Technological Innovation, Clinical Progress, and Challenges

Advanced Healthcare Materials, EarlyView.
This review explores the evolving role of microneedle systems in psoriasis management, highlighting their potential for enhanced drug delivery, diagnosis, and disease monitoring. It also discusses unmet clinical needs for psoriasis management and technical challenges, while outlining strategic directions to advance microneedle integration into routine ...
Fatma Moawad, Yasmine Ruel, Roxane Pouliot, Davide Brambilla   +3 more
wiley   +1 more source

COVID-19 Severity and Mortality in Veterans with Chronic Lung Disease. [PDF]

Ann Am Thorac Soc
Crothers K, Adams SV, Turner AP, Batten L, Nikzad R, Kundzins JR, Fan VS.   +6 more
europepmc   +1 more source

Automating Vascular Biology: An End‐to‐End Automated Workflow for High‐Throughput Blood Vessel‐on‐a‐Chip Production and Multi‐Site Validation

Advanced Healthcare Materials, EarlyView.
AngioPlate384 is a 384‐well open‐top platform that automates production of more than 100 miniaturized, perfusable blood vessels embedded in hydrogel and supported by stromal cells. Stromal‐endothelial co‐culture strengthens blood vessel barrier function and yields responses useful for translational planning. Scalable and automation‐ready, it suits drug
Dawn S. Y. Lin, Hanieh Mohammad Hashemi, Kimia Asadi Jozani, Anushree Chakravarty, Sonya Kouthouridis, Jessica Bonanno, Nicky Anvari, Shravanthi Rajasekar, Feng Zhang, Richard Y. Cheng, Narendra Kumar Singh, Luis Miguel Medina, Marc Durante, Yufang He, Boyang Zhang   +14 more
wiley   +1 more source

Unveiling Biological Age: A New Frontier in Predicting Outcomes in Chronic Lung Disease. [PDF]

Am J Respir Crit Care Med
de Andrade JA, Agudelo Garcia PA, Mora AL.   +2 more
europepmc   +1 more source

Engineered ETS1‐Nanoconjugate Restores Immune Homeostasis through Dual Immune‐Vascular Modulation in Relapsing and Progressive Multiple Sclerosis

Advanced Healthcare Materials, EarlyView.
The biomimetic nanoplatform IMNP (ETS1 pDNA/PBAE@ITP‐MM) undergoes targeted disassembly at inflammatory vascular sites to release the ETS1 plasmid (pETS1). This release initiates a cascade of effects that inhibit pathogenic pathways and support immune homeostasis. (Abbreviations: EndMT, endothelial‐to‐mesenchymal transition; EC, endothelial cell; TC, T
Feng Zhang, Si‐Bo Yang, Yan Luo, Xiao‐Di Sun, Bo‐Hao Chang, Da‐Qiang Zhou, Jun‐Jie Jiang, Ya‐Nan Li, Jie‐Hong Wu, Hui‐Juan Jin, Hang Yang, Hang Hu, Yi‐Fan Zhou, Bo Hu   +13 more
wiley   +1 more source

The PROgnostic ModEl for chronic lung disease (PRO-MEL): development and temporal validation. [PDF]

BMC Pulm Med
Ng SH, Chiam ZY, Chai GT, Kaur P, Yip WF, Low ZJ, Chu J, Tey LH, Neo HY, Tan WS, Hum A.   +10 more
europepmc   +1 more source

Pseudomonas aeruginosa in chronic lung disease: untangling the dysregulated host immune response. [PDF]

Front Immunol
Nickerson R, Thornton CS, Johnston B, Lee AHY, Cheng Z.   +4 more
europepmc   +1 more source

The Saga of COVID-19 in Chronic Lung Disease: History Repeats Itself. [PDF]

Ann Am Thorac Soc
Sharafkhaneh A, Razjouyan J.
europepmc   +1 more source

The Role of the Airway and Gut Microbiome in the Development of Chronic Lung Disease of Prematurity. [PDF]

Pathogens
Boel L, Gallacher DJ, Marchesi JR, Kotecha S.   +3 more
europepmc   +1 more source